Related by context. All words. (Click for frequent words.) 76 administered subcutaneously 72 immunomodulating 72 erlotinib Tarceva ® 72 vinca alkaloid 72 subcutaneously administered 72 liposomal formulation 71 nucleoside analog 71 sodium glucose cotransporter 71 insulin aspart 71 peripherally acting 70 ritonavir boosted 70 Traficet EN 70 HGS ETR2 70 somatostatin analogue 70 MAGE A3 ASCI 70 Blinatumomab 70 interferon alfa 2b 70 sunitinib Sutent ® 70 Pemetrexed 70 Omacetaxine 69 lanreotide 69 Methylnaltrexone 69 ascending dose 69 imatinib resistant 69 intravenously administered 69 Pegasys ® 69 orally administered inhibitor 69 idarubicin 69 PEGylated anti 69 imatinib Gleevec ® 69 selective modulator 69 PKC# 68 leukemia CLL 68 dopamine receptor agonist 68 receptor tyrosine kinase inhibitor 68 fosbretabulin 68 polymerase inhibitor 68 YONDELIS 68 immunomodulator 68 alkylating agent 68 orally bioavailable 68 Orally administered 68 saline placebo 68 dasatinib Sprycel ® 68 proteasome inhibitor 68 selective antagonist 68 CDK inhibitor 68 HCV protease 68 cetuximab Erbitux ® 68 Angiotensin Converting Enzyme 68 Interferon alpha 68 PD LID 68 reuptake inhibitor 68 humanized anti 68 lispro 68 pegylated 68 octreotide acetate 68 Gleevec resistant 67 #HT#A 67 fluticasone furoate 67 TNF Tumor Necrosis Factor 67 echinocandin 67 mertansine 67 pan HDAC inhibitor 67 HCD# [002] 67 administered concomitantly 67 chimeric monoclonal antibody 67 partial agonist 67 erythropoietic 67 beta 1a 67 ceftazidime 67 oxidative stress inducer 67 visilizumab 67 intranasal formulation 67 Phase #b/#a trial 67 histone deacetylase inhibitor 67 oral prodrug 67 CIMZIA TM 67 abacavir lamivudine 67 zoledronate 67 Lubiprostone 67 tigecycline 67 docetaxel Taxotere ® 67 EGFR HER2 67 bortezomib Velcade 67 immunomodulatory 67 Zorbtive TM 67 highly selective inhibitor 67 GAMMAGARD 67 PEGylated Fab fragment 67 6R BH4 67 cytostatic 67 alfa 2a 67 evaluating tivozanib 67 daunorubicin 67 investigational humanized monoclonal antibody 67 5alpha reductase 67 Granulocyte Colony Stimulating Factor 67 Belimumab 67 Vidaza azacitidine 67 CANCIDAS 67 hyaluronidase enzyme 67 bendamustine 67 novel VDA molecule 66 Elesclomol 66 INVANZ 66 ISENTRESS 66 pegfilgrastim 66 immunostimulatory 66 intravesical instillation 66 dyskinesia PD LID 66 posaconazole 66 thalidomide Thalomid 66 receptor inhibitor 66 Temsirolimus 66 subcutaneous SC 66 quetiapine Seroquel 66 pharmacokinetic parameters 66 VAPRISOL 66 uricase 66 alefacept 66 receptor partial agonist 66 Pharmacokinetics PK 66 Bortezomib 66 decitabine 66 chemotherapeutic drug 66 recurrent glioblastoma multiforme 66 anti CD3 66 sorafenib Nexavar 66 MGd 66 doxorubicin cyclophosphamide 66 RhuDex ® 66 pharmacodynamic properties 66 insulin lispro 66 Irinotecan 66 beta2 agonist 66 pegylated interferon alfa 2a 66 cyclophosphamide methotrexate 66 dexamethasone Decadron 66 pharmacokinetics PK 66 Dasatinib 66 cilengitide 66 interferon alfa 66 PDE4 inhibitor 66 GW# [003] 66 fluoroquinolone antibiotic 66 adriamycin 66 substrates inhibitors 66 anti leukemic 66 IAP inhibitor 66 somatostatin analog 66 mGluR5 NAM 66 selective kinase inhibitor 66 Luteinizing Hormone Releasing Hormone 66 humanized monoclonal antibody 66 Copegus ® 66 microtubule inhibitor 66 INCB# [001] 66 bevacizumab Avastin ® 66 Dapagliflozin 66 interferon gamma 1b 66 adipogenic 66 Etoposide 66 radezolid 66 BENICAR 66 pharmacodynamic profile 66 R Saizen R 66 IFN α 66 HuMax CD4 66 APTIVUS r 66 SCH # 66 orally inhaled 66 Neulasta ® 66 platelet inhibitor 66 VELCADE melphalan 66 Hsp# Inhibitor 66 vidofludimus 66 serotonin norepinephrine reuptake inhibitor 66 OMP #M# 66 soluble tumor necrosis 66 topoisomerase II inhibitor 66 angiogenesis inhibitor 66 vapreotide acetate 66 analgesic efficacy 65 administered intranasally 65 insulin sensitizers 65 factor TNF 65 generation purine nucleoside 65 INVEGA ® 65 protein tyrosine phosphatase 1B 65 prucalopride 65 PREZISTA r 65 ENMD # 65 Sym# 65 tenofovir Viread 65 thymalfasin 65 Inhalation Powder 65 xanthine oxidase inhibitor 65 Tocilizumab 65 Sitagliptin 65 SPRYCEL ® 65 Preclinical studies suggest 65 granisetron 65 Vidofludimus 65 clomipramine 65 ganciclovir 65 ADP receptor antagonist 65 MTP inhibitor 65 pathophysiological effects 65 inhibitor RG# 65 histone deacetylase HDAC inhibitor 65 TRAIL R2 65 insulin detemir 65 Elvitegravir 65 Sapacitabine 65 QbG# 65 endothelin receptor antagonists 65 Pegylated 65 T#I [002] 65 vitro cytotoxicity 65 serum phosphorous 65 MEK inhibitor 65 GSK# [001] 65 XL# inhibits 65 pharmacodynamic PD 65 Imprime PGG 65 favorable pharmacokinetic profile 65 preclinical efficacy 65 retapamulin 65 mecamylamine 65 biphasic insulin aspart 65 relapsed MM 65 meropenem 65 direct thrombin inhibitors 65 Serostim R 65 vWF 65 PRTX 65 lanthanum carbonate 65 cetuximab Erbitux R 65 radiolabeled 65 Aflibercept 65 beclomethasone dipropionate 65 AAG geldanamycin analog 65 intravesical 65 NPH insulin 65 mcg dose 65 luteinizing hormone releasing 65 antiandrogens 65 Tarceva TM 65 Bosutinib 65 HMG CoA reductase inhibitor 65 liposomal doxorubicin 65 cell lymphoma CTCL 65 synthetic retinoid 65 angiotensin receptor blocker ARB 65 partial agonists 65 paclitaxel Taxol 65 CG# [003] 65 Nilotinib 65 selective serotonin 2C receptor 65 potent antiproliferative 65 ribavirin RBV 65 Ziprasidone 65 Dalbavancin 65 #HT# 65 Seliciclib 65 BiTE 65 Voreloxin 65 N methyl 65 pioglitazone HCl 65 Clolar ® 65 ascending doses 65 nucleotide analogue 65 liposome injection 65 PEG interferon 65 long acting beta2 65 immune modulatory 65 intravenous dosing 65 bevacizumab Avastin R 65 fumarate 65 Anti VEGF 65 azacytidine 65 Darinaparsin 65 CYT# potent vascular disrupting 65 ZOLINZA 65 #mg/#mg 65 demonstrated antitumor activity 65 topical gel formulation 65 ALN HPN 65 irbesartan 65 primary hypercholesterolemia 65 denileukin diftitox 65 5 HT3 antagonist 65 pegylated liposomal doxorubicin 65 rHuPH# 65 SAR# [004] 65 galiximab 65 tyrosine kinase inhibitor 65 Aptivus ® 65 DAPT 65 active comparator 65 ULORIC 65 Kahalalide F 65 weekly subcutaneous injections 65 sitaxsentan 65 μg dose 65 fosamprenavir 65 Saizen ® 64 idraparinux 64 inhalation powder 64 PEG IFN 64 active moiety 64 non nucleoside inhibitor 64 dacarbazine 64 pharmacokinetic PK profile 64 canakinumab 64 peginterferon alpha 2a 64 Rebif ® 64 Xanafide 64 immunomodulatory therapy 64 pharmacokinetic interactions 64 targeting CD# 64 hormone LHRH antagonist 64 thiazolidinedione TZD 64 fluvastatin 64 Enzastaurin 64 iobenguane 64 subcutaneous formulation 64 5 HT2A receptor 64 DermaVir Patch 64 HSP# inhibitor 64 insulin glulisine 64 flutamide 64 imatinib Gleevec 64 sulindac 64 BAL# [002] 64 small molecule Hedgehog 64 Itraconazole 64 PEG SN# 64 abacavir Ziagen 64 long acting muscarinic 64 biologic therapy 64 Capesaris 64 Albuferon TM 64 HCV replicon 64 quinolone 64 lenalidomide Revlimid R 64 pegylated alpha interferon 64 cannabinor 64 mealtime insulin 64 subcutaneously injected 64 purine analog 64 MabCampath 64 HQK 64 mg TID 64 NXL# 64 CCX# 64 MIRCERA 64 interferon IFN 64 CIMZIA TM certolizumab pegol 64 ciprofloxacin hydrochloride 64 antiplatelet agent 64 IgG1 antibody 64 sulodexide 64 humanized monoclonal 64 Preclinical studies 64 azoles 64 Maribavir 64 AZT zidovudine Retrovir 64 potent antiviral 64 Pathway Inhibitor 64 Panzem R NCD 64 tacrolimus ointment 64 Adalimumab 64 dopamine D2 64 NS#/#A protease 64 LY# [003] 64 Aliskiren 64 amprenavir 64 EGFR tyrosine kinase inhibitors 64 CYT# QbG# 64 GHRH 64 BENICAR HCT 64 IL #E 64 glatiramer acetate 64 interleukin IL -# 64 tocilizumab 64 factor Xa 64 Telmisartan 64 BAY #-# 64 sorafenib tablets 64 dosage regimens 64 targeted antifolate 64 oral antidiabetic 64 safety tolerability pharmacokinetics 64 aspirin clopidogrel 64 cyclin dependent kinase inhibitor 64 injected subcutaneously 64 alpha 2a 64 candesartan cilexetil 64 dihydropyridine 64 5HT 64 TNF alpha selectively neutralizing 64 oral vancomycin 64 FK# 64 colony stimulating factor 64 pimozide 64 TLR9 agonist 64 QD dosing 64 dextromethorphan quinidine 64 Darusentan 64 selective androgen receptor modulator 64 inhaled formulation 64 Pioglitazone 64 HGS ETR1 64 opioid receptor antagonist 64 ganetespib 64 DDP# 64 dihydroergotamine 64 IV bolus 64 Copegus ribavirin 64 mg BID 64 Squalamine 64 VEGF inhibitors 64 crizotinib PF # 64 mapatumumab 64 XOPENEX HFA 64 caspofungin 64 EGFr 64 iloprost 64 AKT inhibitor 64 calcineurin inhibitors 64 HuMax EGFr 64 LY# [002] 64 nucleoside analogue 64 dalteparin 64 INCB# [003] 64 dihydrochloride 64 bispecific 64 potent topoisomerase II 64 oral rivaroxaban 64 arsenic trioxide injection 64 rFSH 64 β blockers 64 EMSAM 64 antimetabolite 64 corticosteroid dexamethasone 64 KRN# 64 oral beclomethasone dipropionate 64 DOXIL 64 selectively binds 64 methylnaltrexone bromide 64 SNRI 64 protease inhibitor PI 64 continuous intravenous infusion 64 DORIBAX 64 pharmacodynamic effects 64 immune stimulatory 64 JAK inhibitor 64 endothelin receptor 64 lamotrigine Lamictal 64 forodesine 64 dihydrofolate reductase 64 NMDA antagonist 64 selective inhibitor 64 IMiDs ® compound 64 milatuzumab 64 certolizumab 64 IMiDs ® 64 Trastuzumab 64 Aclidinium 64 nucleotide analog 64 mesalazine 64 nab paclitaxel 64 SERMs 64 gefitinib Iressa 64 factor G CSF 64 Taxol ® 64 PegIntron 64 Solorel TM 64 uric acid lowering 64 blinded randomized placebo controlled 64 Interferon alpha 2b 64 Fc fusion protein 64 mTOR mammalian target 64 Parkinson disease levodopa induced 64 Inhalation Solution 64 pegylated interferon alpha 64 Chemophase 64 riociguat 64 sipuleucel T 64 adenosine injection 64 pharmacokinetic profiles 64 Linaclotide 64 lytic 64 Vaprisol 64 multikinase inhibitor 64 trastuzumab Herceptin R 64 humanised monoclonal antibody 63 chemotherapeutic agent 63 superficial bladder cancer 63 novel histone deacetylase 63 HGS ETR1 mapatumumab 63 APTIVUS 63 clevidipine 63 anti secretory 63 XP# XP# 63 tumor xenograft models 63 pertuzumab 63 mitomycin 63 Degarelix 63 administered intramuscularly 63 huN# DM1 63 TMC# [002] 63 octreotide 63 Carfilzomib 63 3TC lamivudine Epivir 63 ZD# [001] 63 piperacillin tazobactam 63 potent CYP#A# inhibitors 63 aplindore 63 teriflunomide 63 docetaxel Taxotere R 63 P2Y 63 CIMZIA R 63 SRT# [003] 63 dimeglumine 63 Pimavanserin 63 CCR5 antagonist 63 lenalidomide Revlimid ® 63 nucleoside analogs 63 pharmacodynamics PD 63 trabectedin 63 DU #b 63 reteplase 63 Tyrima 63 TELINTRA 63 polyglutamate 63 peginterferon alfa 2b 63 risperidone Risperdal 63 potent inhibitory 63 antimuscarinic 63 panitumumab Vectibix 63 cytochrome P# #A# 63 PRT# 63 somatostatin 63 Raltegravir 63 direct renin inhibitor 63 relapsed refractory multiple myeloma 63 FUSILEV enhances 63 Talactoferrin 63 LB# [003] 63 monoamine oxidase inhibitors 63 maximally tolerated dose 63 itraconazole 63 intramuscularly 63 plus prednisone prednisolone 63 Receptor Antagonists 63 volociximab 63 carbidopa 63 humanized antibody 63 boosted protease inhibitor 63 Talabostat 63 highly selective endothelin 63 q#h 63 MNTX 63 multicenter randomized placebo controlled 63 CLORETAZINE TM VNP#M 63 systemic RNAi therapeutic 63 ARIKACE 63 melphalan prednisone 63 thiazolides 63 Golimumab 63 peptide antigens 63 5 Fluorouracil 63 Engerix B 63 4mg/kg 63 fenofibric acid 63 rilonacept 63 albinterferon alfa 2b 63 Tezampanel 63 hypereosinophilic syndrome 63 refractory chronic lymphocytic 63 RISPERDAL ® 63 administered orally 63 angiotensin II receptor blocker 63 Decitabine 63 TLK# 63 Inhalation Aerosol 63 novel topoisomerase 63 liposome formulation 63 R lenalidomide 63 Epoetin alfa 63 flavopiridol 63 HBeAg positive 63 Cannabinor 63 mycophenolate mofetil 63 Known hypersensitivity 63 von Willebrand Factor 63 Perforomist TM Inhalation Solution 63 Tiotropium 63 Mg Uk 63 tenofovir emtricitabine 63 anti muscarinic 63 amphotericin B 63 voriconazole 63 HDACi 63 COPEGUS R 63 erythropoiesis stimulating agent 63 DAVANAT 63 immune modulating 63 Tasimelteon 63 phase III isavuconazole 63 mg QD 63 Saquinavir 63 nicardipine 63 MULTAQ 63 ZOMIG 63 potent inhibitor 63 OXi# 63 Fulvestrant 63 dasatinib Sprycel 63 estramustine 63 Paraplatin ® 63 Carbamazepine 63 pharmacologically active isomer 63 GnRH agonist 63 CYC# 63 paricalcitol 63 PNP inhibitor 63 bleomycin 63 sodium stibogluconate 63 macrolide antibiotic 63 gemcitabine carboplatin 63 receptor blockers 63 anti CD3 antibody 63 Enhanze Technology 63 Daptomycin 63 cidofovir 63 IgG1 63 Azedra 63 drug zotarolimus 63 Mycophenolate Mofetil 63 insulin glargine rDNA origin 63 gemcitabine cisplatin 63 RAV# 63 EZN 63 preclinically 63 vascular disrupting agent 63 HCV protease inhibitor 63 Archexin 63 antithrombotic 63 Protelos 63 metformin sulfonylurea 63 nelfinavir 63 Epratuzumab 63 castrate resistant prostate cancer 63 HMG CoA reductase inhibitors 63 trastuzumab Herceptin ® 63 paroxetine sertraline 63 Bruton tyrosine kinase Btk 63 GMX# 63 icatibant 63 metaglidasen 63 VA# [002] 63 Phase IIb Trial 63 Vimpat R 63 Multimeric 63 selectively inhibits 63 APOPTONE 63 bactericidal activity 63 exendin 4 63 YONDELIS R 63 osteoblast 63 goserelin 63 TMC# C# 63 LEXIVA r 63 PEGylated interferon beta 1a 63 XL# XL# 63 ® lenalidomide 63 TNFalpha 63 taxane resistant 63 salmeterol fluticasone 63 inhaled iloprost 63 phosphate S1P 63 generation antisense inhibitor 63 haloperidol Haldol 63 colon carcinoma 63 oral renin inhibitor 63 solithromycin 63 Epidermal Growth Factor Receptor 63 sapropterin dihydrochloride 63 diabetic neuropathic pain 63 6mg 63 pyrazinamide 63 JAK inhibitors 63 ACTEMRA TM 63 antiviral efficacy 63 anticancer agent 63 anti androgen 63 topical ocular 63 agonist LABA 63 pomalidomide 63 dosed orally 63 TACI Ig 63 Thrombin 63 DFMO 63 Faslodex 63 IFN alpha 63 antiandrogen 63 selective agonist 63 Teriflunomide 63 buccal tablet 63 efalizumab 63 potently inhibited 63 Tolvaptan 63 fusidic acid 63 LT NS# 63 hydroxymethyl coenzyme 63 BCR ABL inhibitor 63 PegIFN 63 diarrhea predominant irritable 63 trans retinoic acid 63 PEGINTRON TM 63 Elotuzumab 63 salmeterol inhalation powder 63 busulfan 63 relapsing multiple sclerosis 63 dopamine partial agonist 63 depsipeptide 63 metastatic malignant 63 R baclofen 63 orally dosed 63 fluticasone propionate 63 Ambrisentan 63 GRNVAC1 63 Factor Receptor 63 cediranib 63 catheter occlusion 63 Apidra ® 63 HCV SPRINT 63 syngeneic 63 nilotinib Tasigna ® 63 alvespimycin 63 PXD# 63 factor Xa inhibitor 63 receptor antagonist 63 fludarabine cyclophosphamide 63 NOX E# 63 Tesetaxel 63 Phase Ib study 63 DCCR 63 CTAP# Capsules 63 intradermal injection 63 desvenlafaxine succinate 63 myelodysplastic myeloproliferative diseases 63 abacavir sulfate lamivudine 63 PEGASYS ® 63 immune modulator 63 amikacin 63 antiproliferative 63 non nucleoside 63 Pivotal Phase III 63 danazol 63 cinacalcet 63 pharmacodynamic 63 isoenzyme 63 #mg/m# [001] 63 transcriptase inhibitor NNRTI 63 CIMZIA ™ 63 epoetin alpha 63 hMG 63 INTEGRILIN R 63 BMS # 63 Noxafil 63 receptor subtypes 63 antidiabetic 63 ALVESCO 63 Carvedilol 63 alpha interferons 63 Apoptone 63 JAK2 inhibitor 63 IFN beta 62 Zolinza 62 cynomolgus monkeys 62 xenograft models 62 isoproterenol 62 Ofatumumab 62 #I TM# 62 XmAb# 62 hematological parameters 62 subcutaneously 62 palonosetron 62 antineoplastic 62 advanced metastatic renal 62 PI3K inhibitor 62 AVAPRO 62 hypoxia inducible factor 62 antitumoral 62 Telintra 62 5 HT2C receptor 62 Peginterferon 62 DPP4 62 BROVANA 62 Aplidin R 62 Onconase 62 subcutaneous insulin 62 REBETOL combination therapy 62 ESBA# 62 aripiprazole Abilify 62 pregabalin Lyrica 62 rFIXFc 62 p# MAP kinase inhibitor 62 Neulasta R 62 acyclovir Lauriad R 62 leukemia AML 62 NEUGENE 62 parathyroid hormone PTH 62 Liposomal 62 TAXOTERE R 62 nanomolar range 62 ATL# [001] 62 enkephalin 62 vinorelbine 62 IL 1ß 62 Posaconazole 62 pegylated interferon alfa 62 Cethromycin 62 #mg BID [003] 62 alpha interferon 62 HGS# 62 topically administered 62 PPARgamma 62 cleavable linker 62 vinorelbine tartrate 62 virus HCV protease inhibitor 62 CorVue ™ 62 CA4P 62 ritonavir boosted lopinavir 62 zafirlukast 62 NOXAFIL 62 Humalog ® 62 peripheral blood mononuclear 62 antiinflammatory 62 irreversible inhibitor 62 investigational oral 62 SYN# 62 alkylating 62 Clevudine 62 monoclonal anti 62 Panzem R 62 pegylated interferons 62 cromolyn sodium 62 adalimumab Humira 62 G CSF 62 CD#b 62 thrombopoietin 62 CTA# Injection 62 multicenter Phase II 62 TNF receptor 62 dose cohort 62 Azacitidine 62 protein kinase inhibitor 62 Tamibarotene 62 budesonide 62 leflunomide 62 serotonin reuptake 62 ORMD 62 tenofovir disoproxil fumarate 62 2 methoxyestradiol 62 SCIg 62 Lamotrigine 62 deacetylase inhibitors 62 PSN# [002] 62 leukotriene receptor antagonists 62 BARACLUDE ® 62 #mg doses [002] 62 IMA# 62 Monotherapy 62 HuLuc# 62 Peginterferon alfa 2b 62 D aspartate NMDA receptor 62 Diovan Exforge Tekturna Zelnorm 62 basal bolus regimen 62 conventional DMARDs 62 #mg/day [002] 62 echinocandins 62 FASLODEX 62 pharmacodynamics 62 Anidulafungin 62 CCX# B 62 nucleoside reverse transcriptase inhibitor 62 ACE inhibitor ramipril 62 NMDA antagonists 62 NS5B polymerase 62 Thiovir 62 pharmacokinetic PK study 62 Neupogen ® 62 retaspimycin 62 receptor agonist 62 sunitinib malate 62 TREDAPTIVE 62 subcutaneous injections 62 colesevelam HCl 62 AEGR 62 Mitoxantrone 62 noninferiority 62 oral dual endothelin 62 dose proportionality 62 Doxorubicin 62 Moxifloxacin 62 cytotoxic 62 ARIXTRA 62 RELOVAIR ™ 62 chlorambucil 62 leukotriene receptor antagonist 62 comparator arm 62 INTEGRILIN ® 62 Cetrorelix 62 receptor antagonists 62 Plicera 62 alpha blocker 62 interferon beta 1b 62 serologically active systemic lupus 62 treat benign prostatic 62 topiramate Topamax 62 imatinib mesylate 62 HepG2 cells 62 rFVIIa 62 prokinetic agent 62 Tindamax 62 generation Hsp# inhibitor 62 pyrimidine nucleoside analog 62 Pegloticase 62 LHRH agonist 62 gemcitabine Gemzar ® 62 reslizumab 62 Solulin 62 norethindrone acetate 62 Laquinimod 62 INSPIRE Trial Phase III 62 MYCAMINE 62 nanomolar 62 synthetic progestin 62 investigational monoclonal antibody 62 Methotrexate MTX 62 hormone LHRH 62 Amrubicin 62 mcg kg 62 Factor VIIa 62 Ranolazine 62 Myelodysplastic Syndrome MDS 62 zonisamide SR 62 Zoraxel 62 Interferon alfa 62 SomatoKine 62 Pazopanib 62 Aquavan Injection 62 5 HT6 receptor 62 Lenocta 62 modulator SERM 62 Iloperidone 62 docetaxel chemotherapy 62 immunoconjugate 62 golimumab CNTO 62 effector function 62 ara C 62 novel prodrug 62 coadministration 62 Bicalutamide 62 peptidic compound 62 MYLOTARG 62 ipratropium bromide 62 tipranavir r 62 Ophena TM 62 carboplatin paclitaxel 62 tamoxifen Nolvadex ® 62 ceftriaxone 62 K ras mutations 62 SGLT2 inhibitors 62 cis retinoic acid 62 antitumor 62 RAPTIVA 62 TG# [003] 62 prostanoid 62 PSMA ADC 62 Elitek 62 Leukine ® 62 Amphinex ® 62 radiolabeled monoclonal antibody 62 HCV RESPOND 2 62 biologic DMARD 62 anakinra 62 hyperphenylalaninemia HPA due 62 TRIOLEX 62 receptor blocker 62 lenalidomide dexamethasone 62 budesonide pMDI 62 prodrug